Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
Clinical trial NCT05015426 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05015426
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2025-08-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.